Ciprofloxacin: all 146 studies that test it
Page 2 of 2. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.
- A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult SubjectsCompletedNCT01768663Phase 1
- A Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmoïditis Among AdultsTerminatedNCT01733966Phase 3
- Antibiotics for Klebsiella Liver Abscess StudyCompletedNCT01723150Phase 4
- A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial PneumoniaCompletedNCT01561794Phase 3
- Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) PreventionCompletedNCT01542801Phase 4
- Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung DiseasesCompletedNCT01538667Phase 1
- Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic FibrosisCompletedNCT01400750Phase 4
- Population Pharmacokinetics of Anti-infectious Drugs in ChildrenCompletedNCT01344512Not applicable
- CLL Empirical Antibiotic RegimenCompletedNCT01279252Phase 2
- Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LCCompletedNCT01265173Phase 4
- Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External OtitisCompletedNCT01157819Phase 2
- Efficacy of Surgical Treatment of Osteomyelitis in Diabetic Foot UlcersStatus unknownNCT01137903Not applicable
- To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III)CompletedNCT01072942Phase 1
- Cerebral Antibiotics Distribution After Acute Brain InjuryCompletedNCT01059890Phase 1
- Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01052298Phase 1
- Impact of Formulation on Ciprofloxacin Oral AbsorptionCompletedNCT00992329Phase 1
- A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic SuspensionCompletedNCT00980876Phase 3
- Ph1 Study of Valortim and Ciprofloxacin in HumansSuspendedNCT00964561Phase 1
- Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00961038Phase 1
- Cipro Inhaler for Cystic Fibrosis Children Ages 6-12CompletedNCT00910351Phase 1
- Tissue Characterization in Teeth Treated With a Regeneration ProtocolCompletedNCT00881907Early Phase 1
- Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic PasteCompletedNCT00881491Early Phase 1
- Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis ExternaCompletedNCT00872209Phase 1/2
- Longitudinal Study of the Human Intestinal MicrobiomeCompletedNCT00832286Phase 1
- Febrile Urinary Tract Infection Randomized Short Treatment TrialCompletedNCT00809913Phase 4
- Antibiotic/COPD in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical VentilationCompletedNCT00791505Phase 3
- Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic PatientsWithdrawnNCT00760032Phase 4
- Ciprofloxacin Multiple Dose for Adult CholeraCompletedNCT00741052Phase 3
- Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract InfectionsCompletedNCT00676533Phase 4
- Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract InfectionsCompletedNCT00669994Phase 4
- Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract InfectionsCompletedNCT00668122Phase 3
- Ciprofloxacin on Burned PatientsCompletedNCT00668044Phase 3
- Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mgCompletedNCT00650351Phase 1
- Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mgCompletedNCT00649662Phase 1
- Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mgCompletedNCT00649155Phase 1
- Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common UropathogensCompletedNCT00481689Phase 4
- Short or Long Schemes of Antibiotic Prophylaxis for Prostate BiopsyTerminatedNCT00294749Phase 3
- Study of Antibiotics in the Treatment of Colonic Crohn's DiseaseTerminatedNCT00257699Phase 2
- Parameters Associated With the Emergence of Resistance to Ciprofloxacin in Human Commensal FloraTerminatedNCT00190151Not applicable
- Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical TrialCompletedNCT00142272Phase 3
- Monoclonal Antibody for Treatment of Inhalation AnthraxCompletedNCT00138411Phase 1
- Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic DiseasesCompletedNCT00137787Phase 3
- Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient SettingTerminatedNCT00107081Phase 3
- Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With CancerTerminatedNCT00062231Not applicable
- S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder CancerTerminatedNCT00003824Phase 3
- A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.CompletedNCT00000641Phase 2